Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]

Lorenza Rimassa^{1

2}, Angela Lamarca³, Grainne M O'Kane^{4

5}, Julien Edeline⁶, Mairéad G McNamara⁷, Arndt Vogel^{8

9

10}, Matteo Fassan^{11

12}, Alejandro Forner^{13

14}, Timothy Kendall^{15

16

17}, Jorge Adeva¹⁸, Andrea Casadei-Gardini¹⁹, Lorenzo Fornaro²⁰, Antoine Hollebecque²¹, Maeve A Lowery²², Teresa Macarulla²³, David Malka²⁴, Elene Mariamidze²⁵, Monica Niger²⁶, Anu Ustav²⁷, John Bridgewater²⁸, Rocio I R Macias^{14

29}, Chiara Braconi^{17

30

31}

Affiliations

¹ Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan, 20072, Italy.
² Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via A. Manzoni 56, Rozzano, Milan, 20089, Italy.
³ Department of Medical Oncology, Oncohealth Institute, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Fundación Jimenez Diaz University Hospital, Avda Reyes Católicos 2, Madrid, 28040, Spain.
⁴ University College Dublin, Belfield, Dublin 4, Ireland.
⁵ Department of Medical Oncology, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
⁶ INSERM, Department of Medical Oncology, University Rennes, CLCC Eugène Marquis, COSS [(Chemistry Oncogenesis Stress Signaling)] - UMR_S 1242, Rennes, F-35000, France.
⁷ Division of Cancer Sciences, University of Manchester & Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
⁸ Toronto General Hospital, UHN, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada.
⁹ Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada.
¹⁰ Hannover Medical School, Carl-Neuberg Str. 1, Hannover, 30659, Germany.
¹¹ Department of Medicine (DIMED), University of Padua, Via Gabelli 61, Padua, 35121, Italy.
¹² Veneto Institute of Oncology (IOV-IRCCS), Via Gattamelata 64, Padua, 35128, Italy.
¹³ Liver Unit, Barcelona Clinic Liver Cancer (BCLC) Group, ICMDM, Hospital Clinic IDIBAPS, University of Barcelona, Villarroel 170, Barcelona, 08036, Spain.
¹⁴ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Av. Monforte de Lemos, 3-5, Madrid, 28029, Spain.
¹⁵ Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, 5 Little France Drive, Edinburgh, EH16 4UU, UK.
¹⁶ Edinburgh Pathology, University of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, UK.
¹⁷ CRUK Scotland Cancer Centre, Switchback Rd, Glasgow, G61 1BD, UK.
¹⁸ Department of Medical Oncology, Hospital Universitario 12 de Octubre, Av. de Córdoba, s/n, Usera, Madrid, 28041, Spain.
¹⁹ Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Via Olgettina 60, Milan, 20132, Italy.
²⁰ Medical Oncology 2 Unit, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, Pisa, 56126, Italy.
²¹ Département de Médecine Oncologique, Gustave Roussy, 114 Rue Edouard Vaillant, Villejuif, F-94805, France.
²² Trinity St James Cancer Institute, Trinity College Dublin, College Green, Dublin 2, Ireland.
²³ Vall d'Hebrón Institute of Oncology (VHIO), Vall d'Hebrón University Hospital, Centre Cellex, Carrer de Natzaret, 115-117, Barcelona, 08035, Spain.
²⁴ Department of Medical Oncology, Institut Mutualiste Montsouris, 42 Boulevard Jourdan, Paris, 75014, France.
²⁵ Department of Oncology and Hematology, Todua Clinic, Tevdore Mgvdeli #13, Tbilisi, 0112, Georgia.
²⁶ Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, Milan, 20133, Italy.
²⁷ Clinic of Oncology, North-Estonian Medical Centre, Sytiste Rd 19, Tallinn, 13419, Estonia.
²⁸ UCL Cancer Institute, 72 Huntley St, London, WC1E 6DD, UK.
²⁹ Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, University of Salamanca, IBSAL, CIBERehd, Campus M. Unamuno s/n, Salamanca, 37007, Spain.
³⁰ School of Cancer Sciences, University of Glasgow, Switchback Rd, Glasgow, G61 1QH, UK.
³¹ Beatson West of Scotland Cancer Centre, 1053 Great Western Rd, Glasgow, G12 0YN, UK.

PMID: 40385615
PMCID: PMC12083903
DOI: 10.1016/j.lanepe.2025.101306

Published Erratum

Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]

Lorenza Rimassa et al. Lancet Reg Health Eur. 2025.

. 2025 Apr 30:53:101306.

doi: 10.1016/j.lanepe.2025.101306. eCollection 2025 Jun.

Authors

Affiliations

¹ Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan, 20072, Italy.
² Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via A. Manzoni 56, Rozzano, Milan, 20089, Italy.
³ Department of Medical Oncology, Oncohealth Institute, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Fundación Jimenez Diaz University Hospital, Avda Reyes Católicos 2, Madrid, 28040, Spain.
⁴ University College Dublin, Belfield, Dublin 4, Ireland.
⁵ Department of Medical Oncology, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
⁶ INSERM, Department of Medical Oncology, University Rennes, CLCC Eugène Marquis, COSS [(Chemistry Oncogenesis Stress Signaling)] - UMR_S 1242, Rennes, F-35000, France.
⁷ Division of Cancer Sciences, University of Manchester & Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
⁸ Toronto General Hospital, UHN, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada.
⁹ Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada.
¹⁰ Hannover Medical School, Carl-Neuberg Str. 1, Hannover, 30659, Germany.
¹¹ Department of Medicine (DIMED), University of Padua, Via Gabelli 61, Padua, 35121, Italy.
¹² Veneto Institute of Oncology (IOV-IRCCS), Via Gattamelata 64, Padua, 35128, Italy.
¹³ Liver Unit, Barcelona Clinic Liver Cancer (BCLC) Group, ICMDM, Hospital Clinic IDIBAPS, University of Barcelona, Villarroel 170, Barcelona, 08036, Spain.
¹⁴ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Av. Monforte de Lemos, 3-5, Madrid, 28029, Spain.
¹⁵ Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, 5 Little France Drive, Edinburgh, EH16 4UU, UK.
¹⁶ Edinburgh Pathology, University of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, UK.
¹⁷ CRUK Scotland Cancer Centre, Switchback Rd, Glasgow, G61 1BD, UK.
¹⁸ Department of Medical Oncology, Hospital Universitario 12 de Octubre, Av. de Córdoba, s/n, Usera, Madrid, 28041, Spain.
¹⁹ Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Via Olgettina 60, Milan, 20132, Italy.
²⁰ Medical Oncology 2 Unit, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, Pisa, 56126, Italy.
²¹ Département de Médecine Oncologique, Gustave Roussy, 114 Rue Edouard Vaillant, Villejuif, F-94805, France.
²² Trinity St James Cancer Institute, Trinity College Dublin, College Green, Dublin 2, Ireland.
²³ Vall d'Hebrón Institute of Oncology (VHIO), Vall d'Hebrón University Hospital, Centre Cellex, Carrer de Natzaret, 115-117, Barcelona, 08035, Spain.
²⁴ Department of Medical Oncology, Institut Mutualiste Montsouris, 42 Boulevard Jourdan, Paris, 75014, France.
²⁵ Department of Oncology and Hematology, Todua Clinic, Tevdore Mgvdeli #13, Tbilisi, 0112, Georgia.
²⁶ Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, Milan, 20133, Italy.
²⁷ Clinic of Oncology, North-Estonian Medical Centre, Sytiste Rd 19, Tallinn, 13419, Estonia.
²⁸ UCL Cancer Institute, 72 Huntley St, London, WC1E 6DD, UK.
²⁹ Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, University of Salamanca, IBSAL, CIBERehd, Campus M. Unamuno s/n, Salamanca, 37007, Spain.
³⁰ School of Cancer Sciences, University of Glasgow, Switchback Rd, Glasgow, G61 1QH, UK.
³¹ Beatson West of Scotland Cancer Centre, 1053 Great Western Rd, Glasgow, G12 0YN, UK.

PMID: 40385615
PMCID: PMC12083903
DOI: 10.1016/j.lanepe.2025.101306

Abstract

[This corrects the article DOI: 10.1016/j.lanepe.2024.101170.].

PubMed Disclaimer

Erratum for

New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe.
Rimassa L, Lamarca A, O'Kane GM, Edeline J, McNamara MG, Vogel A, Fassan M, Forner A, Kendall T, Adeva J, Casadei-Gardini A, Fornaro L, Hollebecque A, Lowery MA, Macarulla T, Malka D, Mariamidze E, Niger M, Ustav A, Bridgewater J, Macias RIR, Braconi C. Rimassa L, et al. Lancet Reg Health Eur. 2025 Feb 19;50:101170. doi: 10.1016/j.lanepe.2024.101170. eCollection 2025 Mar. Lancet Reg Health Eur. 2025. PMID: 40093395 Free PMC article. Review.

References

1. Pant S, Fan J, Oh D-Y, et al. Zanidatamab in previously-treated HER2-positive (HER2+) biliary tract cancer (BTC): overall survival (OS) and longer follow-up from the phase 2b HERIZON-BTC-01 study. J Clin Oncol. 2024;42(suppl 16) abstr 4091.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]

Affiliations

Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]

Authors

Affiliations

Abstract

Erratum for

References

Publication types

LinkOut - more resources

Full Text Sources